?dherence and Persistence to Oral Anticoagulation in ?F Patients With Previous Ischemic Stroke

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03463421
• Date of registration: 21/02/2018
• Prospective Registration: Yes
• Primary sponsor: University of Thessaly
• Public title: ?dherence and Persistence to Oral Anticoagulation in ?F Patients With Previous Ischemic Stroke ADHERE-OAC
• Scientific title: A Prospective Assessment of Adherence and Persistence to Oral Anticoagulation in Ischemic Stroke Patients With Atrial Fibrillation: Incidence, Predictors and the Prognostic Role of the SAMe-TT2R2 Score.
• Date of first enrolment: June 1, 2018
• Target sample size: 1200
• Recruitment status: Recruiting
• URL: https://clinicaltrials.gov/show/NCT03463421
• Study type: Observational [Patient Registry]

Countries of recruitment

Finland, Greece

Contacts

• Name: George Ntaios, MD, PhD

• Name: George Ntaios, MD, PhD
• Affiliation: Medical School, University of Thessaly, Larissa University Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Previous ischemic stroke

- Atrial fibrillation

- Age >18 years

- Informed consent

Exclusion Criteria:

-



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Ischemic Stroke

Primary Outcome(s)

Adherence to medication [Time Frame: Up to 5 years]

Secondary Outcome(s)

Proportion of patients still on the initial anticoagulant at the time of follow-up assessment [Time Frame: Up to 5 years]

Secondary ID(s)

ERISTA 2016

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of Helsinki